AMGN
Amgen Inc
NASDAQ: AMGN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$346.25
+2.43% today
Updated 2026-04-29
Market cap
$182.22B
P/E ratio
23.75
P/S ratio
4.96x
EPS (TTM)
$14.23
Dividend yield
2.80%
52W range
$253 – $391
Volume
2.6M
Amgen Inc (AMGN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
21.00%
Operating margin
30.50%
ROE
106.10%
ROA
7.93%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $14.27B | $2.95B | 85.32% | 26.91% | 20.68% |
| 2007 | $14.77B | $3.17B | 82.75% | 26.94% | 21.43% |
| 2008 | $15.00B | $4.20B | 84.70% | 34.75% | 27.97% |
| 2009 | $14.64B | $4.61B | 85.72% | 37.60% | 31.45% |
| 2010 | $15.05B | $4.63B | 85.25% | 36.84% | 30.74% |
| 2011 | $15.58B | $3.68B | 84.42% | 27.67% | 23.64% |
| 2012 | $17.27B | $4.34B | 83.10% | 32.30% | 25.17% |
| 2013 | $18.68B | $5.08B | 82.08% | 31.41% | 27.21% |
| 2014 | $20.06B | $5.16B | 77.96% | 30.86% | 25.71% |
| 2015 | $21.66B | $6.94B | 80.49% | 39.10% | 32.03% |
| 2016 | $22.99B | $7.72B | 81.90% | 42.60% | 33.59% |
| 2017 | $22.85B | $1.98B | 82.19% | 43.65% | 8.66% |
| 2018 | $23.75B | $8.39B | 82.73% | 43.22% | 35.35% |
| 2019 | $23.36B | $7.84B | 81.35% | 41.41% | 33.57% |
| 2020 | $25.42B | $7.26B | 75.77% | 35.95% | 28.57% |
| 2021 | $25.98B | $5.89B | 75.16% | 29.40% | 22.68% |
| 2022 | $26.32B | $6.55B | 75.66% | 36.34% | 24.89% |
| 2023 | $28.19B | $6.72B | 70.02% | 28.01% | 23.83% |
| 2024 | $33.42B | $4.09B | 61.53% | 21.71% | 12.24% |
| 2025 | $36.74B | $7.71B | 70.80% | 29.06% | 20.99% |